GS

Guy Sauvageau

CEO and CSO

ExCellThera

Montreal, Quebec


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
ExCellThera
Industry
research
Employees
19.0
Seniority
C suite
Total Funding
6000000.0
Latest Funding
Other

Technologies

Mimecast Microsoft Office 365 GoDaddy Hosting Amazon AWS Mobile Friendly Google Tag Manager reCAPTCHA Gravity Forms Apache WordPress.org Remote

Keywords

blood stem cell expansion bioengineering immune cells health care gene therapy cell engineering hsct hsc cell therapy blood cancer leukemia aml mds biotech biotechnology cord blood bone marrow peripheral blood transplant stem cells biotechnology research cell expansion hsc rejuvenation um171 hematopoietic stem cells blood cancer treatment allogeneic therapy clinical trials innovative therapies gmp grade bioengineering solutions primitive hscs non manipulative cells therapeutic use pipeline preclinical research immunology oncology hematology novel therapies functional cells stem cell engineering drug master file patient treatment clinical validation enhanced cell therapy treatment advances stem cell biology therapeutic innovations hematological malignancies stemness preservation cell culture ex vivo expansion therapeutic molecules fda collaboration clinical research molecular mechanisms patient outcomes investigational drug biotech showcase multidisciplinary team quality assurance processes scalable solutions scientific publications research collaboration cancer care patient first approach health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans